유방 생검 기기 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2024-2034년)
Breast Biopsy Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
상품코드:1508477
리서치사:Transparency Market Research
발행일:2024년 05월
페이지 정보:영문 190 Pages
라이선스 & 가격 (부가세 별도)
한글목차
유방 생검 기기 시장 - 조사 범위
TMR의 조사 보고서 "세계의 유방 생검 기기 시장"은 2024년부터 2034년까지의 예측 기간 동안 시장 지표에 대한 귀중한 통찰력을 얻기 위해 과거뿐만 아니라 현재의 성장 동향과 기회를 조사했습니다. 이 보고서는 2024년을 기준연도로, 2034년을 예측 연도로 하여 2018년부터 2034년까지 세계 유방 생검 기기 시장의 수익과 예측을 제공합니다. 또한 2024년부터 2034년까지 세계 유방 생검 기기 시장의 연평균 복합 성장률(CAGR%)도 제공합니다.
이 보고서는 광범위한 1차 연구, KOL(Key Opinion Leader), 업계 리더 및 오피니언 제조업체와의 인터뷰, 주요 기업의 제품 자료, 연례 보고서, 보도 자료, 관련 문서 등을 참조한 2차 연구, 그리고 유방 생검 기기 시장을 이해하기 위해 주요 기업의 제품 자료, 연례 보고서, 보도 자료 및 관련 문헌을 참조하여 작성되었습니다.
시장 현황
2023년 시장 규모
21억 달러
2034년 시장 규모
39억 달러
CAGR
5.7%
이 보고서는 세계 유방 생검 기기 시장의 경쟁 환경을 조사했습니다. 세계 유방 생검 기기 시장에서 사업을 운영하는 주요 기업이 확인되었으며, 각 기업은 다양한 속성으로 프로파일링되었습니다. 기업 개요, 재무 상태, 최근 동향, SWOT 등은 이 보고서에서 소개하는 세계 유방 생검 기기 시장 기업의 속성입니다.
목차
제1장 서문
제2장 전제조건과 조사 방법
제3장 주요 요약
제4장 시장 개요
서론
개요
시장 역학
세계 시장 분석과 예측, 2020-2034년
제5장 주요 인사이트
파이프라인 분석
주요 제품/브랜드 분석
주요 M&A
COVID-19의 산업에 대한 영향
제6장 세계 시장 분석과 예측 : 제품 유형별
서론과 정의
주요 조사 결과와 발전
시장 매출 예측 : 제품 유형별, 2020-2034년
코어 침 생검 기기
진공 보조 생검 기기
세침흡인 생검 기기
외과용 생검 기기
기타
시장의 매력 : 제품 유형별
제7장 세계 시장 분석과 예측 : 가이드 방법
서론과 정의
주요 조사 결과와 발전
시장 매출 예측 : 가이드 방법, 2020-2034년
초음파 가이드하 생검
MRI 가이드하 생검
맘모그래피 가이드하 생검
정위 가이드하 생검
시장의 매력 : 가이드 방법별
제8장 세계 시장 분석과 예측 : 용도별
서론과 정의
주요 조사 결과와 발전
시장 매출 예측 : 용도별, 2020-2034년
스크리닝
진단
모니터링
시장의 매력 : 용도별
제9장 세계 시장 분석과 예측 : 최종사용자별
서론과 정의
주요 조사 결과와 발전
시장 매출 예측 : 최종사용자별, 2020-2034년
병원
전문 클리닉
영상진단센터
외래수술센터(ASC)
시장의 매력 : 최종사용자별
제10장 세계 시장 분석과 예측 : 지역별
주요 조사 결과
시장 매출 예측 : 지역별, 2020-2034년
북미
유럽
아시아태평양
라틴아메리카
중동 및 아프리카
시장의 매력 : 지역별
제11장 북미 시장 분석과 예측
제12장 유럽 시장 분석과 예측
제13장 아시아태평양 시장 분석과 예측
제14장 라틴아메리카 시장 분석과 예측
제15장 중동 및 아프리카 시장 분석과 예측
제16장 경쟁 구도
시장 기업 - 경쟁 매트릭스(기업 Tier 및 규모별)
시장 점유율 분석 : 기업별(2023년)
기업 개요
Hologic, Inc.
Becton, Dickinson and Company(BD)
Medtronic
Danaher Corporation
Siemens Healthineers AG
Mammotome(Devicor Medical Products, Inc.)
Carestream Health
AURORA HEALTHCARE US CORP.
Stryker
LSH
영문 목차
영문목차
Breast Biopsy Devices Market - Scope of Report
TMR's report on the global breast biopsy devices market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global breast biopsy devices market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global breast biopsy devices market from 2024 to 2034.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the breast biopsy devices market.
Market Snapshot
Market Value in 2023
US$ 2.1 Bn
Market Value in 2034
US$ 3.9 Bn
CAGR
5.7%
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global breast biopsy devices market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global breast biopsy devices market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global breast biopsy devices market.
The report delves into the competitive landscape of the global breast biopsy devices market. Key players operating in the global breast biopsy devices market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global breast biopsy devices market profiled in this report.
Key Questions Answered in Global breast biopsy devices Market Report:
What is the sales/revenue generated by breast biopsy devices across all regions during the forecast period?
What are the opportunities in the global breast biopsy devices market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which segment is expected to generate the highest revenue globally in 2034?
Which segment is projected to expand at the highest CAGR during the forecast period?
What are the market positions of different companies operating in the global market?
Breast Biopsy Devices Market - Research Objectives and Research Approach
The comprehensive report on the global breast biopsy devices market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global breast biopsy devices market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global breast biopsy devices market.
Table of Contents
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Breast Biopsy Devices Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Breast Biopsy Devices Market Analysis and Forecast, 2020-2034
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Breast Biopsy Devices Market Analysis and Forecast, by Product Type
6.1. Introduction and Definitions
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Product Type, 2020-2034
6.3.1. Core Needle Biopsy Devices
6.3.2. Vacuum-assisted Biopsy Devices
6.3.3. Fine Needle Aspiration Biopsy Devices
6.3.4. Surgical Biopsy Devices
6.3.5. Others
6.4. Market Attractiveness, by Product Type
7. Global Breast Biopsy Devices Market Analysis and Forecast, by Guidance Technique
7.1. Introduction and Definitions
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Guidance Technique, 2020-2034
7.3.1. Ultrasound-guided Biopsy
7.3.2. MRI-guided Biopsy
7.3.3. Mammography-guided Biopsy
7.3.4. Stereotactic-guided Biopsy
7.4. Market Attractiveness, by Guidance Technique
8. Global Breast Biopsy Devices Market Analysis and Forecast, by Application
8.1. Introduction and Definitions
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Application, 2020-2034
8.3.1. Screening
8.3.2. Diagnostic
8.3.3. Surveillance
8.4. Market Attractiveness, by Application
9. Global Breast Biopsy Devices Market Analysis and Forecast, by End-user
9.1. Introduction and Definitions
9.2. Key Findings/Developments
9.3. Market Value Forecast, by End-user, 2020-2034
9.3.1. Hospitals
9.3.2. Specialty Clinics
9.3.3. Diagnostic Imaging Centers
9.3.4. Ambulatory Surgical Centers
9.4. Market Attractiveness, by End-user
10. Global Breast Biopsy Devices Market Analysis and Forecast, by Region
10.1. Key Findings
10.2. Market Value Forecast, by Region, 2020-2034
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Market Attractiveness, by Region
11. North America Breast Biopsy Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Product Type, 2020-2034
11.2.1. Core Needle Biopsy Devices
11.2.2. Vacuum-assisted Biopsy Devices
11.2.3. Fine Needle Aspiration Biopsy Devices
11.2.4. Surgical Biopsy Devices
11.2.5. Others
11.3. Market Attractiveness, by Product Type
11.4. Market Value Forecast, by Guidance Technique, 2020-2034
11.4.1. Ultrasound-guided Biopsy
11.4.2. MRI-guided Biopsy
11.4.3. Mammography-guided Biopsy
11.4.4. Stereotactic-guided Biopsy
11.5. Market Attractiveness, by Guidance Technique
11.6. Market Value Forecast, by Application, 2020-2034
11.6.1. Screening
11.6.2. Diagnostic
11.6.3. Surveillance
11.7. Market Attractiveness, by Application
11.8. Market Value Forecast, by End-user, 2020-2034
11.8.1. Hospitals
11.8.2. Specialty Clinics
11.8.3. Diagnostic Imaging Centers
11.8.4. Ambulatory Surgical Centers
11.9. Market Attractiveness, by End-user
11.10. Market Value Forecast, by Country, 2020-2034
11.10.1. U.S.
11.10.2. Canada
11.11. Market Attractiveness Analysis
11.11.1. By Product Type
11.11.2. By Guidance Technique
11.11.3. By Application
11.11.4. By End-user
11.11.5. By Country
12. Europe Breast Biopsy Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Product Type, 2020-2034
12.2.1. Core Needle Biopsy Devices
12.2.2. Vacuum-assisted Biopsy Devices
12.2.3. Fine Needle Aspiration Biopsy Devices
12.2.4. Surgical Biopsy Devices
12.2.5. Others
12.3. Market Attractiveness, by Product Type
12.4. Market Value Forecast, by Guidance Technique, 2020-2034
12.4.1. Ultrasound-guided Biopsy
12.4.2. MRI-guided Biopsy
12.4.3. Mammography-guided Biopsy
12.4.4. Stereotactic-guided Biopsy
12.5. Market Attractiveness, by Guidance Technique
12.6. Market Value Forecast, by Application, 2020-2034
12.6.1. Screening
12.6.2. Diagnostic
12.6.3. Surveillance
12.7. Market Attractiveness, by Application
12.8. Market Value Forecast, by End-user, 2020-2034
12.8.1. Hospitals
12.8.2. Specialty Clinics
12.8.3. Diagnostic Imaging Centers
12.8.4. Ambulatory Surgical Centers
12.9. Market Attractiveness, by End-user
12.10. Market Value Forecast, by Country/Sub-region, 2020-2034
12.10.1. Germany
12.10.2. U.K.
12.10.3. France
12.10.4. Italy
12.10.5. Spain
12.10.6. Rest of Europe
12.11. Market Attractiveness Analysis
12.11.1. By Product Type
12.11.2. By Guidance Technique
12.11.3. By Application
12.11.4. By End-user
12.11.5. By Country/Sub-region
13. Asia Pacific Breast Biopsy Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Product Type, 2020-2034
13.2.1. Core Needle Biopsy Devices
13.2.2. Vacuum-assisted Biopsy Devices
13.2.3. Fine Needle Aspiration Biopsy Devices
13.2.4. Surgical Biopsy Devices
13.2.5. Others
13.3. Market Attractiveness, by Product Type
13.4. Market Value Forecast, by Guidance Technique, 2020-2034
13.4.1. Ultrasound-guided Biopsy
13.4.2. MRI-guided Biopsy
13.4.3. Mammography-guided Biopsy
13.4.4. Stereotactic-guided Biopsy
13.5. Market Attractiveness, by Guidance Technique
13.6. Market Value Forecast, by Application, 2020-2034
13.6.1. Screening
13.6.2. Diagnostic
13.6.3. Surveillance
13.7. Market Attractiveness, by Application
13.8. Market Value Forecast, by End-user, 2020-2034
13.8.1. Hospitals
13.8.2. Specialty Clinics
13.8.3. Diagnostic Imaging Centers
13.8.4. Ambulatory Surgical Centers
13.9. Market Attractiveness, by End-user
13.10. Market Value Forecast, by Country/Sub-region, 2020-2034
13.10.1. China
13.10.2. Japan
13.10.3. India
13.10.4. Australia & New Zealand
13.10.5. Rest of Asia Pacific
13.11. Market Attractiveness Analysis
13.11.1. By Product Type
13.11.2. By Guidance Technique
13.11.3. By Application
13.11.4. By End-user
13.11.5. By Country/Sub-region
14. Latin America Breast Biopsy Devices Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Product Type, 2020-2034
14.2.1. Core Needle Biopsy Devices
14.2.2. Vacuum-assisted Biopsy Devices
14.2.3. Fine Needle Aspiration Biopsy Devices
14.2.4. Surgical Biopsy Devices
14.2.5. Others
14.3. Market Attractiveness, by Product Type
14.4. Market Value Forecast, by Guidance Technique, 2020-2034
14.4.1. Ultrasound-guided Biopsy
14.4.2. MRI-guided Biopsy
14.4.3. Mammography-guided Biopsy
14.4.4. Stereotactic-guided Biopsy
14.5. Market Attractiveness, by Guidance Technique
14.6. Market Value Forecast, by Application, 2020-2034
14.6.1. Screening
14.6.2. Diagnostic
14.6.3. Surveillance
14.7. Market Attractiveness, by Application
14.8. Market Value Forecast, by End-user, 2020-2034
14.8.1. Hospitals
14.8.2. Specialty Clinics
14.8.3. Diagnostic Imaging Centers
14.8.4. Ambulatory Surgical Centers
14.9. Market Attractiveness, by End-user
14.10. Market Value Forecast, by Country/Sub-region, 2020-2034
14.10.1. Brazil
14.10.2. Mexico
14.10.3. Rest of Latin America
14.11. Market Attractiveness Analysis
14.11.1. By Product Type
14.11.2. By Guidance Technique
14.11.3. By Application
14.11.4. By End-user
14.11.5. By Country/Sub-region
15. Middle East & Africa Breast Biopsy Devices Market Analysis and Forecast
15.1. Introduction
15.1.1. Key Findings
15.2. Market Value Forecast, by Product Type, 2020-2034
15.2.1. Core Needle Biopsy Devices
15.2.2. Vacuum-assisted Biopsy Devices
15.2.3. Fine Needle Aspiration Biopsy Devices
15.2.4. Surgical Biopsy Devices
15.2.5. Others
15.3. Market Attractiveness, by Product Type
15.4. Market Value Forecast, by Guidance Technique, 2020-2034
15.4.1. Ultrasound-guided Biopsy
15.4.2. MRI-guided Biopsy
15.4.3. Mammography-guided Biopsy
15.4.4. Stereotactic-guided Biopsy
15.5. Market Attractiveness, by Guidance Technique
15.6. Market Value Forecast, by Application, 2020-2034
15.6.1. Screening
15.6.2. Diagnostic
15.6.3. Surveillance
15.7. Market Attractiveness, by Application
15.8. Market Value Forecast, by End-user, 2020-2034
15.8.1. Hospitals
15.8.2. Specialty Clinics
15.8.3. Diagnostic Imaging Centers
15.8.4. Ambulatory Surgical Centers
15.9. Market Attractiveness, by End-user
15.10. Market Value Forecast, by Country/Sub-region, 2020-2034
15.10.1. GCC Countries
15.10.2. South Africa
15.10.3. Rest of Middle East & Africa
15.11. Market Attractiveness Analysis
15.11.1. By Product Type
15.11.2. By Guidance Technique
15.11.3. By Application
15.11.4. By End-user
15.11.5. By Country/Sub-region
16. Competition Landscape
16.1. Market Player - Competition Matrix (By Tier and Size of Companies)
16.2. Market Share Analysis, by Company (2023)
16.3. Company Profiles
16.3.1. Hologic, Inc.
16.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.1.2. Product Portfolio
16.3.1.3. Financial Overview
16.3.1.4. SWOT Analysis
16.3.1.5. Strategic Overview
16.3.2. Becton, Dickinson and Company (BD)
16.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.2.2. Product Portfolio
16.3.2.3. Financial Overview
16.3.2.4. SWOT Analysis
16.3.2.5. Strategic Overview
16.3.3. Medtronic
16.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.3.2. Product Portfolio
16.3.3.3. Financial Overview
16.3.3.4. SWOT Analysis
16.3.3.5. Strategic Overview
16.3.4. Danaher Corporation
16.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.4.2. Product Portfolio
16.3.4.3. Financial Overview
16.3.4.4. SWOT Analysis
16.3.4.5. Strategic Overview
16.3.5. Siemens Healthineers AG
16.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.5.2. Product Portfolio
16.3.5.3. Financial Overview
16.3.5.4. SWOT Analysis
16.3.5.5. Strategic Overview
16.3.6. Mammotome (Devicor Medical Products, Inc.)
16.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.6.2. Product Portfolio
16.3.6.3. Financial Overview
16.3.6.4. SWOT Analysis
16.3.6.5. Strategic Overview
16.3.7. Carestream Health
16.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.7.2. Product Portfolio
16.3.7.3. Financial Overview
16.3.7.4. SWOT Analysis
16.3.7.5. Strategic Overview
16.3.8. AURORA HEALTHCARE US CORP.
16.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.3.8.2. Product Portfolio
16.3.8.3. Financial Overview
16.3.8.4. SWOT Analysis
16.3.8.5. Strategic Overview
16.3.9. Stryker
16.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)